AHA 2020 Scientific Sessions Preview: Late-breaking Science, Days 1, 2 and 3
What to watch during the AHA 2020 late-breaking science sessions? We break down the first 3 days of clinical trial presentations for you, here.
Higher Green Tea and Coffee Intake May Reduce Mortality Risk in Patients with T2D
A new study of Japanese adults with type 2 diabetes found dual consumption of green tea and coffee reduced mortality risk by >60%.
Pfizer COVID-19 Vaccine Candidate Achieves 90% Efficacy
Pfizer/BioNTech announced more than 90% efficacy for their vaccine against SARS-CoV-2 infection in the first interim analysis of phase 3 study.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 9, 2020
Global confirmed cases of COVID-19 have surpassed 50 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Ticagrelor Wins Label Expansion to Reduce Risk of Recurrent Stroke, TIA
FDA approval is based on results of the phase III THALES trial, in which DAPT with ticagrelor and aspirin for 30 days reduced the rate of stroke and death by 17% vs aspirin alone.
COPD Self-management App Reduces Exacerbations, Readmissions vs Usual Care
Use of the myCOPD app after hospitalization for acute COPD exacerbation reduced subsequent exacerbations by nearly 50%, according to study authors.
Telemedicine Gains More Ground During COVID-19
A recent survey conducted by Doximity found that US physician and patient adoption of telemedicine is quickly rising amid the COVID-19 pandemic.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 6, 2020
Global confirmed cases of COVID-19 have surpassed 48 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
CLINICAL FOCUS COLLECTION: Obesity
Obesity, a complex chronic disease in itself, underlies many of the fatal cardiac and cardiometabolic diseases of the 21st century. Find a wide collection of expert guidance in this collection.
Pharmacotherapy for Obesity Should Begin in Primary Care
Video: Obesity expert Dr Louis Aronne outlines the role of medication in obesity treatment and says primary care is absolutely the place to begin.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 5, 2020
How many cases of COVID-19 have been confirmed in the US? How many people have been tested? Get your daily COVID-19 update here.
COVID-19 Patients with Obesity Have Lower Inflammatory Biomarkers, Study Finds
Obese patients hospitalized with COVID-19 had lower levels of inflammation biomarkers but outcomes similar to non-obese patients with elevated levels of those biomarkers.
Is BMI a Risk Factor for Severe COVID-19 Outcomes? New Research Says “No”
New research presented at ObesityWeek®2020 showed no statistical difference in severe COVID-19 outcomes between normal and obese patients.
Telemedicine Services among Patients with Obesity during Quarantine Linked to Weight Loss, Healthier Eating
Patients with obesity who utilized telemedicine services during quarantine achieved an average 2 kg weight loss, according to new research presented at the ObesityWeek®2020 virtual meeting.
Statin Use Lowers Mortality Among Patients with Diabetes Hospitalized with COVID-19
Adults with diabetes admitted to a New York City hospital with COVID-19 had a lower mortality risk if they received a statin, a new study found.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 4, 2020
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
CLINICAL FOCUS COLLECTION: Preventive Cardiology
Preventive Cardiology Collection Table of Contents: Expert video interviews, short, clinical guideline-focused quizzes, facts at-a-glance slideshows, plus news.
COVID-19 Lockdown Sidelines Weight Control Effort Among Obese Youth
A longitudinal study of weight reduction in adolescents was redesigned to accommodate pandemic lockdown--and the results are very concerning.
Aspirin Reduces COVID-19 Mortality: Investigator's Insights
Dr Jonathan Chow reviews study findings that patients with COVID-19 taking low-dose aspirin had reduced risk for use of ICU, mechanical ventilation, and of death.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 3, 2020
